Enzymatica recruits Chief Financial Officer
06 September 2017 - 9:30PM
Press release
Lund, 6 September, 2017
Enzymatica recruits Chief
Financial Officer
Enzymatica has recruited Therese
Filmersson as its new Chief Financial Officer - CFO. Therese joins
us from Procurator, one of Sweden's leading wholesale companies in
areas including protective clothing, hygiene articles and office
materials. She has a great deal of experience from financial
positions with companies at MTG. Therese Filmersson will take up
her post on 1 January 2018, and will join Enzymatica's management
team.
-
"We are delighted to recruit Therese - with her
considerable experience in expanding companies, she will have a
vital input in securing our continued growth", says Fredrik
Lindberg, CEO of Enzymatica.
-
"I am looking forward to contributing to
Enzymatica's international expansion. With its unique product, the
ColdZyme® spray for treating the common cold, Enzymatica has every
opportunity to continue its strong growth", says Therese
Filmersson.
Therese Filmersson will now be resigning from her
position as CFO and Deputy CEO of the Procurator Group, which has
sales of around SEK 1.2 billion, with companies in Sweden, Denmark,
Norway, Finland and Estonia.
Alongside her responsibilities for Procurator's Finance Department,
she also worked in areas such as HR, legal, logistics and strategic
IT. Before that, Therese was Finance Director of MTG Internet
Retailing, CFO of CDON, Business Area Controller at MTG,
CFO/operational Finance Manager at TV Shop Europe AB, Controller/HR
Manager at Bravida Syd AB and Controller at ABB Installation,
Division South.
For
more information, please contact:
Fredrik Lindberg, CEO, Enzymatica AB
Tel: +46 (0)708-86 53 70 | E-mail:
fredrik.lindberg@enzymatica.com
About Enzymatica AB
Enzymatica AB is a medical device company that develops and sells
medical devices for infection-related diseases. In a short period
of time, the company has developed ColdZyme®, a unique mouth spray
for the common cold, has launched the product in eight markets and
has established it among the top-selling cold products in Swedish
kronor terms at Swedish pharmacies. The strategy is to continue to
grow by strengthening the company's position in existing markets
and expanding into new geographical markets through established
partners. The company is headquartered in Lund and is listed on
Nasdaq First North. For more information,
visit: www.enzymatica.se
Enzymatica's Certified Adviser is Erik Penser Bank.
Phototheresefilmersson
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Enzymatica AB via Globenewswire
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024